Preview

Ultrasound & Functional Diagnostics

Advanced search

Middle cerebral artery peak systolic velocity and cardiothoracic ratio in fetuses with severe anemia and hydrops

https://doi.org/10.24835/1607-0771-2022-4-30-42

Abstract

Objective: to assess and compare the values of peak systolic velocity in the middle cerebral artery (PSV MCA) and cardiothoracic ratio (CTR) in groups of fetuses suffering from severe anemia with hydrops fetalis and severe anemia without hydrops.

Material and methods: pregnant women with no fetal congenital abnormalities were divided to the 3 groups. The group 1 (n = 13) consisted of women with singleton pregnancy with severe fetal anemia with hydrops. The group 2 (n = 12) consisted of women with singleton pregnancy with severe fetal anemia without signs of hydrops. Multiple intrauterine transfusions were performed in groups 1 and 2. Women with normal pregnancy and outcomes were included to the group 3 (n = 368) for assessing of normal CTR values in fetuses.

Results: there were no significant differences of PSV MCA values between groups 1 and 2 (P = 0.093). On the other hand, the significant differences of CTR values obtained between groups 1 and 2 (P = 0.035). The CTR values in group 1 were higher than in group 2.

Conclusion: CTR value can be considered as an indicator of condition severity in fetuses with severe anemia.

About the Author

A. V. Makogon
Avicenna Medical Center, Mother & Child Group of Companies
Russian Federation

A.V. Makogon – M.D., Ph.D., Head of Fetal Medicine Group, Avicenna Medical Center

Novosibirsk



References

1. Scheier M., Hernandez-Andrade E., Carmo A., Dezerega V., Nicolaides K.H. Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity. Ultrasound Obstet. Gynecol. 2004; 23 (5): 432–436. https://doi.org/10.1002/uog.1010

2. Blackburn S.T. Maternal, fetal, and neonatal physiology. 4th ed. Elsevier Health Sciences, 2012, pp. 270–280.

3. Thammavong K., Luewan S., Jatavan P., Tongsong T. Foetal haemodynamic response to anaemia. ESC Heart Fail. 2020; 7 (6): 3473–3482. https://doi.org/10.1002/ehf2.12969

4. Makogon A.V., Neverov A.V., Andryushina I.V. Fetal middle cerebral artery peak systolic velocity and cardiothoracic ratio in fetal anemia diagnosis. Ultrasound and Functional Diagnostics. 2022; 2: 28–48. https://doi.org/10.24835/1607-0771-2022-2-28-48 (in Russian)

5. Mari G., Norton M.E., Stone J., Berghella V., Sciscione A.C., Tate D., Schenone M.H. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia – diagnosis and management. Am. J. Obstet. Gynecol. 2015; 212 (6): 697–710. https://doi.org/10.1016/j.ajog.2015.01.059

6. Clinical practice guidelines Rhesus isoimmunization. Hemolytic disease of the fetus, https://cr.minzdrav.gov.ru/recomend/596_2 (2020, accessed 20.11.2022). (in Russian)

7. Zhetishev R.A., Shabalov N.P., Ivanov D.O. Anemia of newborns. Diagnosis, prevention, treatment. Clinical recommendations, https://www.mrckb.ru/files/anemia.pdf (2015, accessed 20.11.2022). (in Russian)

8. Makogon A.V., Volkova V.M., Andryushina I.V. Reference values of fetal middle cerebral artery peak systolic velocity (12–40 weeks of gestation). Ultrasound and Functional Diagnostics. 2021; 3: 90–103. https://doi.org/10.24835/1607-0771-2021-3-90-103 (in Russian)

9. Mari G. Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story. Ultrasound Obstet. Gynecol. 2005; 25 (4): 323–330. https://doi.org/10.1002/uog.1882

10. Scikit-learn documentation, https://scikit-learn. org (2022, accessed 20.11.2022)

11. Mari G., Deter R.L., Carpenter R.L., Rahman F., Zimmerman R., Moise K.J. Jr., Dorman K.F., Ludomirsky A., Gonzalez R., Gomez R., Oz U., Detti L., Copel J.A., Bahado-Singh R., Berry S., Martinez-Poyer J., Blackwell S.C. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N. Engl. J. Med. 2000; 342 (1): 9–14. https://doi.org/10.1056/NEJM200001063420102

12. Davis L., Thornburg K.L., Giraud G.D. The effects of anaemia as a programming agent in the fetal heart. J. Physiol. 2005; 565 (Pt 1): 35–41. https://doi.org/10.1113/jphysiol.2004.082388

13. Weiner C.P. Fetal hemolytic disease. In: James D.K., Steer P.J., Weiner C.P., Gonic B. (eds.) High risk pregnancy: management options. 3rd ed. Philadelphia: Elsevier Saunders, 2006, pp. 291–312.

14. Li X., Zhou Q., Zhang M., Tian X., Zhao Y. Sonographic markers of fetal α-thalassemia major. J. Ultrasound Med. 2015; 34 (2): 197–206. https://doi.org/10.7863/ultra.34.2.197

15. Makogon A.V., Andryushina I.V. Haemolytic disease of the fetus: monitoring, treatment of the fetus and delivery. Gynecology, Obstetrics and Perinatology. 2018; 17 (3): 45–52. https://doi.org/10.20953/1726-1678-2018-3-45-52 (in Russian)

16. Hernandez-Andrade E., Scheier M., Dezerega V., Carmo A., Nicolaides K.H. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet. Gynecol. 2004; 23 (5): 442–445. https://doi.org/10.1002/uog.1009

17. Borna S., Mirzaie F., Hanthoush-Zadeh S., Khazardoost S., Rahimi-Sharbaf F. Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of nonimmune hydrops. J. Clin. Ultrasound. 2009; 37 (7): 385–388. https://doi.org/10.1002/jcu.20613

18. Hasnani-Samnani Z., Mahmoud M.I., Farid I., Al Naggar E., Ahmed B. Non-immune hydrops: Qatar experience. J. Matern. Fetal Neonatal. Med. 2013; 26 (5): 449–453. https://doi.org/10.3109/14767058.2012.733781

19. Srisupundit K., Luewan S., Tongsong T. Prenatal diagnosis of fetal heart failure. Diagnostics (Basel). 2023; 13 (4): 779. https://doi.org/10.3390/diagnostics13040779

20. Opie L.H., Commerford P.J., Gersh B.J., Pfeffer M.A. Controversies in ventricular remodelling. Lancet. 2006; 367 (9507): 356–367. https://doi.org/10.1016/s0140-6736(06)68074-4

21. Grossman W., Paulus W.J. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. J. Clin. Invest. 2013; 123 (9): 3701–3703. https://doi.org/10.1172/jci69830

22. Kalyuzhin V.V., Teplyakov A.T., Solovtsov M.A., Kalyuzhina E.V., Bespalova I.D., Terentyeva N.N. Remodeling of the left ventricle: one or several scenarios? Bulletin of Siberian Medicine. 2016; 15 (4): 120–139. https://doi.org/10.20538/1682-0363-2016-4-120-139 (in Russian)

23. Copel J.A., Grannum P.A., Green J.J., Belanger K., Hanna N., Jaffe C.C., Hobbins J.C., Kleinman C.S. Fetal cardiac output in the isoimmunized pregnancy: a pulsed Doppler-echocardiographic study of patients undergoing intravascular intrauterine transfusion. Am. J. Obstet. Gynecol. 1989; 161 (2): 361–365. https://doi.org/10.1016/0002-9378(89)90520-6

24. Abbasi N., Johnson J.A., Ryan G. Fetal anemia. Ultrasound Obstet. Gynecol. 2017; 50 (2): 145–153. https://doi.org/10.1002/uog.17555

25. Westgren M., Lingman G., Stangenberg M. Oxygenation of the human fetus as a function of hemoglobulin concentration. Am. J. Perinatol. 1994; 11 (1): 9–13. https://doi.org/10.1055/s-2007-994524

26. Geaghan S.M. Fetal laboratory medicine: on the frontier of maternal-fetal medicine. Clin. Chem. 2012; 58 (2): 337–352. https://doi.org/10.1373/clinchem.2011.166991

27. Gozzo M.L., Noia G., Barbaresi G., Colacicco L., Serraino M.A., De Santis M., Lippa S., Calla C., Caruso A., Mancuso S., Giardina B. Reference intervals for 18 clinical chemistry analytes in fetal plasma samples between 18 and 40 weeks of pregnancy. Clin. Chem. 1998; 44 (3): 683–685.

28. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 1998; 179 (1): 194–202. https://doi.org/10.1016/s0002-9378(98)70272-8

29. Makogon A.V., Varaksin N.A., Pikalov I.V., Andryushina I.V. Hemostasis and inflammatory response syndrome in fetus with hemolytic disease. Vestnik NSU. Series: Biology and Clinical Medicine. 2011; 9 (2): 70–74. (in Russian)

30. Makagon A.V., Andryushina I.V. Diagnosis and management of fetal hemolytic disease. Obstetrics and Gynecology. 2012; 1: 43–48. (in Russian)


Review

For citations:


Makogon A.V. Middle cerebral artery peak systolic velocity and cardiothoracic ratio in fetuses with severe anemia and hydrops. Ultrasound & Functional Diagnostics. 2022;(4):30-42. (In Russ.) https://doi.org/10.24835/1607-0771-2022-4-30-42

Views: 132


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1607-0771 (Print)
ISSN 2408-9494 (Online)